Muscle Relaxant Drugs Market - Top Companies and Manufacturers

In the year 2024, the industry size of muscle relaxant drugs is evaluated at USD 3.4 Million.

The muscle relaxant drugs market size was valued at USD 3.2 Million in 2023 and is expected to reach USD 7.54 Million by the end of 2036, expanding at around 6.8% CAGR during the forecast period i.e., between 2024-2036. Upsurge in the use of muscle relaxants with other anaesthetics during surgical procedures, increasing sedentary lifestyle and decreasing levels of activity are the major factors driving the growth of the market.

North America is likely to dominate majority industry share by 2036, driven by upsurge in healthcare expenditure, low physical activity along with the high prevalence of musculoskeletal conditions affecting people of all ages in the region.

AbbVie Inc., Antisense Therapeutics Limited, Sandoz International GmbH, Abbott Laboratories, Pfizer, Inc., Merck & Co., Inc., SteriMax Inc., Vertical Pharmaceuticals, LLC, Instas Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd.